构建稳定转化的BmN细胞表达人白介素-28A及表达产物的体外抗肿瘤活性  被引量:2

Establishment of Stably Transformed BmN Cells Expressing Human Interlukin-28A and in vitro Anti-tumor Activity of the Expressed Product

在线阅读下载全文

作  者:陆叶[1] 郑小坚[2] 薛仁宇[2] 曹广力[2] 沈卫德[2] 贡成良[2] 

机构地区:[1]苏州大学药学院,江苏苏州215123 [2]苏州大学基础医学与生物科学学院,江苏苏州215123

出  处:《蚕业科学》2010年第3期452-457,共6页ACTA SERICOLOGICA SINICA

基  金:国家重点基础研究发展计划"973"项目(No.2005CB-121000)

摘  要:为建立能表达人白介素-28A(hIL-28A)基因的稳定转化家蚕卵巢细胞(BmN)系,构建了重组表达载体pIZT/V5-His-hIL-28A并转染BmN细胞,采用终浓度为300~400μg/mL的博莱霉素(zeocin)筛选2个月后,获得了稳定转化BmN细胞系。SDS-PAGE和Western blotting检测显示在稳定转化BmN细胞中表达的重组hIL-28A蛋白分子质量约为26kD;用ELISA试剂盒测定hIL-28A的表达水平约为2.035×10-5ng/个细胞。用噻唑蓝法(MTT法)检测hIL-28A的体外抗肿瘤活性,结果显示其对肺癌细胞A549、急性早幼粒细胞白血病细胞HL60、肝癌细胞BEL-7402和乳腺癌细胞M231的半数抑制浓度(IC50)分别为3.21、2.84、6.29和9.32ng/mL。研究结果表明hIL-28A可在稳定转化BmN细胞中表达,表达产物具有体外抗肿瘤活性。In order to establish a stably transformed silkworm BmN cell line which can continuously express human interlukin-28A (hIL-28A) gene, a recombinant expression vector pIZT/V5-His-h/L-28A was constructed and used to transfect BmN cells. After screening with 300 -400μg/mL zeocin (the final concentration) for two months, a stably transformed BmN cell line expressing hIL-28A was obtained. SDS-PAGE and Western blotting results indicated that the recombinant hIL-28A protein expressed in the stably transformed cells had a molecular weight of about 26 kD. The expression level of hIL-28A, determined by ELISA, was about 2. 035 ng in 105 cells. In vitro anti-tumor activity of hIL-28A by MTT assay revealed that the 50% inhibitory concentration (ICso) of the recombinant hIL-28A on A549 ( lung cancer cells), HL60 (acute promyelocytic leukemia cells), BEL-7402 (liver cancer cells) and M231 cells (breast cancer cells) was approximately 3.21, 2.84, 6.29 and 9.32 ng/mL, respectively. It was concluded that hIL-28A could be stably expressed in the transformed BmN cells, and has certain anti-tumor activity in vitro.

关 键 词:人白介素-28A 转化BmN细胞 基因表达 抗肿瘤活性 

分 类 号:Q78[生物学—分子生物学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象